# Rajib Biswas

> Founder of CytoHub

CEO & Co-Founder at CytoHub, an AI-powered biotech platform advancing regenerative cell therapies, starting with treatments for heart disease.

Former Director of Technology Evaluation for Cell Therapy at Resilience ($8.8B valuation), backed by ARCH Venture Partners and Mubadala.

Previously Process Development Lead for Cardiac Cell Therapy at Sana Biotechnology (IPO $6B+), where I helped scale PSC-derived therapies for clinical use.

Stanford GSB alum with deep expertise in iPSC-derived therapeutics, bioprocessing, clinical readiness, and building biotech teams at the intersection of AI and cell therapy.

Things I can advise on:
✔️ Building biotech from R&D to platform
✔️ Scaling iPSC & cell therapy tech
✔️ AI integration in drug development
✔️ Fundraising from top biotech VCs
✔️ Translating science to product
✔️ Building cross-functional R&D teams
✔️ Strategic partnerships in life sciences

Helping founders bring advanced therapies to market—faster, smarter, and at scale.

## Offerings

- Video call (15 min): $150.00

## Links

- [Expert profile](/RajibBiswas)
- [Avatar](https://media.intro.co/avatars/1198625ZG_XdcMG.jpg)
- [Marketplace](/marketplace)